Clinical Trials · NCT06326060
A Research Study Comparing How Well Different Doses of the Medicine NN0519-0130 Help People With Excess Body Weight Lose Weight
- Phase
- Phase 2
- Recruitment status
- Completed
- Sponsor
- Novo Nordisk A/S
- Enrollment
- 354
- Start date
- Mar 2024
- Locations
- 70 sites, 3 countries
- Primary endpoint
- Relative change in body weight